Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections.

Amer El Ghali Ashlan J Kunz CoyneKristen LucasMolly TiemanXhilda XhemaliSuet-Ping LauGabriela IturraldeAndrew PurdyDana J HolgerEsther GarciaMichael P VeveMichael Joseph Rybak

Published in: Microbiology spectrum (2024)

CFDC was safe and clinically effective as a monotherapy or in combination in treating a variety of carbapenem-resistant gram-negative infections. Further prospective studies are warranted to confirm these findings.

Keyphrases

gram negative
multidrug resistant
drug resistant
acinetobacter baumannii
combination therapy
randomized controlled trial
case control
pseudomonas aeruginosa